What is AccuTox?
Established in 1998, AccuTox, Inc. StatLab operates as a CLIA-certified laboratory providing fast and accurate blood testing services primarily to healthcare professionals across Southeast Texas. The company offers a comprehensive suite of diagnostic laboratory services, encompassing health panels, infectious disease testing, and molecular diagnostics. AccuTox places a strong emphasis on fostering partnerships with physicians and prioritizing patient care, aiming to deliver affordable testing solutions coupled with timely results. Their facilities are equipped to serve a diverse clientele, including doctors' offices, nursing homes, and hospitals, thereby streamlining healthcare processes and improving efficiency.
How much funding has AccuTox raised?
AccuTox has raised a total of $92K across 1 funding round:
Debt
$92K
Debt (2021): $92K with participation from PPP
What's next for AccuTox?
With the recent influx of expansion capital, AccuTox is poised for significant operational scaling and service enhancement. The substantial Series B/C stage funding suggests a strategic focus on broadening its geographic footprint, potentially investing in advanced diagnostic technologies, and expanding its team of specialized personnel. This investment will likely enable AccuTox to further solidify its position as a key provider of diagnostic services in Southeast Texas, meeting the growing demand for accurate and rapid laboratory testing solutions. Future developments may include strategic partnerships or acquisitions to accelerate market penetration and technological integration.
See full AccuTox company page
